April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Norrin Increases Vessel Integrity upon VEGF Induced Permeability
Author Affiliations & Notes
  • Wendy Dailey
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Kevin Roumayah
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Mei Cheng
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Charlote Massol
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Kimberly A Drenser
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Kenneth P Mitton
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Michael Thomas Trese
    Pediatric Retinal Research Laboratory, Eye Research Institute, Oakland University, Rochester, MI
  • Footnotes
    Commercial Relationships Wendy Dailey, None; Kevin Roumayah, None; Mei Cheng, None; Charlote Massol, None; Kimberly Drenser, None; Kenneth Mitton, None; Michael Trese, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5400. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wendy Dailey, Kevin Roumayah, Mei Cheng, Charlote Massol, Kimberly A Drenser, Kenneth P Mitton, Michael Thomas Trese; Norrin Increases Vessel Integrity upon VEGF Induced Permeability. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5400.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The purpose of this study was to examine the effect of norrin on VEGF induced vessel permeability. VEGF signaling is induced by ischemic retina and it reduces the cell-to-cell adherence of vessel endothelial cells. Norrin is a growth factor that is necessary for normal retinal vascular development and maintenance.

Methods: Confluent human retinal microvascular endothelial cells (HRMEC) were treated with VEGF (or TGF-β) alone or in combination with Norrin. After 24 hours, changes in morphology and junction protein localization were assessed by immunstaining with antibodies to an adherens junction protein, VE-cadherin (VE-Cad), or a tight junction protein, claudin-5 (Cln5). To determine expression levels, RT-PCR was performed after the above treatments using a Cln5 TaqMan assay. To correlate the disruption in cell junction proteins with an increase in permeability, norrin was injected into the vitreous of OIR mice at P14. At P17, the mice were injected (IP) with Evans Blue dye and sacrificed two hours later. The retinas were immediately fixed, flat mounted and examined by fluorescence microscopy to visualize dye leakage from vessels.

Results: Treatment with VEGF and TGF-β had a similar effect upon cell morphology and junction protein localization. The cells became elongated and there was a decrease in Cln5 and VE-Cad localization at the cell borders. Cells treated in combination with Norrin, however, maintained their cobblestone appearance and had more junction protein staining. Expression assays revealed an increase in Cln5 mRNA in the cells treated in combination with norrin compared to VEGF or TGF-β treatment alone. Finally, Norrin seemed to reduce the amount of permeability caused by the OIR model. Norrin treated eyes generally had leakage only at the terminal endothelial cell buds whereas control OIR eyes had a more diffuse leakage pattern along the length of vessels.

Conclusions: This investigation provides evidence that Norrin overcomes the loss of endothelial cell-to-cell junction proteins that occurs upon VEGF stimulation and thereby reduces VEGF induced vessel permeability. By focusing on the initial BRB breakdown, treatment with norrin may be able to prevent VEGF induced pathology.

Keywords: 446 cell adhesions/cell junctions • 609 neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×